Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective

• Main Authors: Bagepally BS (Author), Chaikledkaew U (Author), Youngkong S (Author), Anothaisintawee T (Author), Thavorncharoensap M (Author), Dejthevaporn C (Author), Thakkinstian A (Author)
• Format: Book
• Published: Dove Medical Press, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bhavani Shankara Bagepally,1,2 Usa Chaikledkaew,1,3 Sitaporn Youngkong,1,3 Thunyarat Anothaisintawee,1,4 Montarat Thavorncharoensap,1,3 Charungthai Dejthevaporn,5 Ammarin Thakkinstian1,6 1Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand;...